Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneum01:21

Peritoneum

10.8K
The peritoneum is a vital membrane that lines the abdominal cavity and covers most of the organs within it. It plays a crucial role in protecting the organs, providing a smooth surface for their movement, and facilitating various physiological processes. Understanding the anatomy and function of the peritoneum is essential for comprehending the complexities of the abdominal region.
Anatomy of the Peritoneum
The peritoneum is divided into two layers: the parietal peritoneum and the visceral...
10.8K
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

4.8K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
4.8K
Tissue Membranes01:27

Tissue Membranes

10.5K
A tissue membrane is a thin layer of cells that covers the outside of the body, the organs, internal passageways that lead to the exterior of the body, and the lining of the moveable joint cavities. There are two basic types of tissue membranes— connective tissue and epithelial membranes.
Connective Tissue Membranes
The connective tissue membrane is formed solely from connective tissue. These membranes encapsulate organs, such as the kidneys, and line our movable joints. A synovial...
10.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Position statement of the SEN Anemia Working Group: A critical and contextualized adaptation of the KDIGO 2026 anemia guidelines to the Spanish setting.

Nefrologia·2026
Same author

Preserving Peritoneal Membrane Performance.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

VExUS Point-of-Care Ultrasound Tool to Detect Changes in Volume Status: A Prospective Observational Study.

JACC. Advances·2026
Same author

Core Interventions for the Prevention of Peritoneal Dialysis-Related Infections.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Outcomes and Decision Stability in Older Adults following Structured Counseling on Dialysis versus Conservative Management for Kidney Failure: A Prospective Study.

Nephron·2025
Same author

Incremental start and clinical outcomes in peritoneal dialysis: International results from PDOPPS.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2025

Related Experiment Video

Updated: Mar 8, 2026

Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR
08:56

Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR

Published on: June 27, 2017

8.4K

Peritoneal Membrane Preservation.

M Auxiliadora Bajo1, Gloria Del Peso2, Isaac Teitelbaum3

  • 1Home Dialysis Unit, Nephrology Department, La Paz University Hospital, Madrid, Spain.

Seminars in Nephrology
|February 4, 2017
PubMed
Summary
This summary is machine-generated.

Peritoneal dialysis (PD) can cause peritoneal fibrosis and ultrafiltration failure due to inflammation and non-biocompatible fluids. Strategies like biocompatible solutions and renin-angiotensin-aldosterone system blockade may preserve the peritoneal membrane.

Keywords:
Peritoneal dialysisperitoneal fibrosisperitoneal membranepreventive measurestherapeutic interventions

More Related Videos

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

27.2K
Isolation of Mouse Peritoneal Cavity Cells
04:32

Isolation of Mouse Peritoneal Cavity Cells

Published on: January 28, 2010

145.8K

Related Experiment Videos

Last Updated: Mar 8, 2026

Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR
08:56

Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR

Published on: June 27, 2017

8.4K
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

27.2K
Isolation of Mouse Peritoneal Cavity Cells
04:32

Isolation of Mouse Peritoneal Cavity Cells

Published on: January 28, 2010

145.8K

Area of Science:

  • Nephrology
  • Regenerative Medicine
  • Biomaterials Science

Background:

  • Peritoneal dialysis (PD) is a vital renal replacement therapy.
  • Long-term PD can lead to peritoneal fibrosis and ultrafiltration failure.
  • Inflammation from peritonitis and bioincompatible PD fluids are key contributors.

Purpose of the Study:

  • To review functional and structural alterations in the peritoneal membrane during PD.
  • To discuss strategies for preventing these alterations and preserving membrane function.
  • To evaluate the potential of new PD fluids and therapeutic agents.

Main Methods:

  • Literature review of studies on peritoneal dialysis complications.
  • Analysis of factors contributing to peritoneal membrane damage.
  • Evaluation of proposed preventative strategies and therapeutic interventions.

Main Results:

  • New, more biocompatible PD solutions show promise but require further clinical morphologic studies.
  • Blockade of the renin-angiotensin-aldosterone system is a potentially effective strategy.
  • Several other agents show efficacy in experimental studies but lack human trials.

Conclusions:

  • Preserving the peritoneal membrane is crucial for long-term PD success.
  • Biocompatible PD fluids and renin-angiotensin-aldosterone system blockade are promising avenues.
  • Further research, particularly human trials, is needed for novel therapeutic agents.